Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UK Awaits MHRA Medical Device Fee Consultation While Regulatory Costs Mount

This article was originally published in SRA

Executive Summary

The UK Medicines and Healthcare Products Regulatory Agency's widely anticipated consultation on medical device fees is being delayed as official processes of scrutiny are still being finalized1,2. However, MHRA director of devices John Wilkinson was upbeat last week at the annual regulatory conference of the Association of British Healthcare Industries, saying: “We hope the consultation will be out next month, and when released it will be a proper exercise of six weeks or so.”

Advertisement
Advertisement
UsernamePublicRestriction

Register